These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 19895230

  • 1. Primary and secondary prevention of cervical cancer.
    Grce M.
    Expert Rev Mol Diagn; 2009 Nov; 9(8):851-7. PubMed ID: 19895230
    [Abstract] [Full Text] [Related]

  • 2. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL, Coutlée F, Ferenczy A.
    Public Health Genomics; 2009 Nov; 12(5-6):352-61. PubMed ID: 19684447
    [Abstract] [Full Text] [Related]

  • 3. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.
    Franco EL, Harper DM.
    Vaccine; 2005 Mar 18; 23(17-18):2388-94. PubMed ID: 15755633
    [Abstract] [Full Text] [Related]

  • 4. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I.
    Klin Mikrobiol Infekc Lek; 2006 Jun 18; 12(3):91-7. PubMed ID: 17051469
    [Abstract] [Full Text] [Related]

  • 5. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M, Jasani B, Fiander A.
    Vaccine; 2007 Apr 20; 25(16):3007-13. PubMed ID: 17292517
    [Abstract] [Full Text] [Related]

  • 6. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.
    Franco EL, Ferenczy A.
    Future Oncol; 2007 Jun 20; 3(3):319-27. PubMed ID: 17547527
    [Abstract] [Full Text] [Related]

  • 7. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar 20; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

  • 8. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [Abstract] [Full Text] [Related]

  • 9. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE, Unger ER, Saraiya M.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638
    [No Abstract] [Full Text] [Related]

  • 10. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM.
    Nat Clin Pract Oncol; 2007 Apr 01; 4(4):224-35. PubMed ID: 17392713
    [Abstract] [Full Text] [Related]

  • 11. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX.
    Expert Opin Pharmacother; 2011 Oct 01; 12(14):2189-204. PubMed ID: 21756205
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 13. HPV vaccines: state of the art.
    D'Andrilli G, Bovicelli A, Giordano A.
    J Cell Physiol; 2010 Sep 19; 224(3):601-4. PubMed ID: 20432468
    [Abstract] [Full Text] [Related]

  • 14. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A, Monk BJ.
    Oncologist; 2005 Aug 19; 10(7):528-38. PubMed ID: 16079320
    [Abstract] [Full Text] [Related]

  • 15. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Aug 19; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M.
    Clin Microbiol Infect; 2012 Oct 19; 18 Suppl 5():64-9. PubMed ID: 22862799
    [Abstract] [Full Text] [Related]

  • 17. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M, Dillner J.
    J Clin Virol; 2007 Mar 19; 38(3):189-97. PubMed ID: 17258503
    [Abstract] [Full Text] [Related]

  • 18. Prevention of cervical cancer.
    Denny L.
    Reprod Health Matters; 2008 Nov 19; 16(32):18-31. PubMed ID: 19027619
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun 19; 16(89):91-4. PubMed ID: 17582921
    [Abstract] [Full Text] [Related]

  • 20. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 19; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.